Risk of doubting that has a heart attack again Weight-reducing medicine of Abbott Laboratories Company " The promise is beautiful and graceful (Meridia) " Stop selling in North America

Risk of doubting that has a heart attack again Weight-reducing medicine of Abbott Laboratories Company " The promise is beautiful and graceful (Meridia) " Stop selling in North America
Risk of doubting that has a heart attack again Weight-reducing medicine of Abbott Laboratories Company " The promise is beautiful and graceful (Meridia) " Stop selling in North America
According to American media, American Abbott Laboratories company (AbbottLaboratories) Announce on October 8, its weight-reducing medicine promise with a history of 13 years is beautiful and graceful (Meridia) Will stop selling in the lower shelf of the American and Canadian market, the reason is that American food medicines supervise the administration bureau thinking, taking the promise beautifully and gracefully will increase patient's having a heart attack and risk of apoplexy of heart disease. This administration bureau claims, nearly 100,000 Americans are taking the promise beautifully and gracefully at present, 80% among them are middle aged women, the user's average medicine time is 50 days, lighten by 5 and weigh oneself on average (about 2.3 kilograms) . This office expert think consumer take such weight-reducing medicine " whether weight-reducing result very much limited " ,Consider, get the medicine have the intersection of health and risk, under the two weigh, should not let the health become the victim. The intersection of Canada and Ministry of Public Health show Abbott Laboratories company stop, sell promise in Canada to be American and graceful voluntarily while being earlier 8 day. Criticized and listed on the whole world since 1997, this medicine had already added the two countries to sell in U.S.A. for over 10 years. As far back as January of this year, the medicines regulator of Europe finds, after the heart disease patient takes the promise beautifully and gracefully, it have a heart attack and risk of apoplexy increase 1% than patient that does not take, this product lower shelf that then compel. The medicines of U.S.A. and Canada supervise personnel but based on this data to make the same decision now. In recent years, the sales amount with beautiful and graceful promise has already glided by a wide margin. Abbott Laboratories company expect the intersection of medicine and sales amount global this to lower than 100 million dollars 2010, sales amount in U.S.A. will be lower than 30 million dollars. The quantity that U.S.A. opened such weight-reducing medicine prescription was 283,000 last year, just half in 2005. According to domestic media, the promise is too beautiful and graceful to sell on the Chinese market at present.


|